Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer

NCT00024492 is registered in ClinicalTrials.gov with INSYS Therapeutics Inc as lead sponsor.

NCT NCT00024492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00024492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer
Lead sponsor
INSYS Therapeutics Inc
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2001
Completion date
June 30, 2004
Enrollment
40
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

tumors